241 related articles for article (PubMed ID: 23050586)
21. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer.
Kwong J; Lee JY; Wong KK; Zhou X; Wong DT; Lo KW; Welch WR; Berkowitz RS; Mok SC
Neoplasia; 2006 Apr; 8(4):268-78. PubMed ID: 16756719
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Silencing of Tumor Suppressor lncRNA
Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of the tumor suppressor genes SPI1, PRDX2, KLF4, DLEC1, and DAPK1 in childhood and adolescent lymphomas.
Özdemir İ; Pınarlı FG; Pınarlı FA; Aksakal FNB; Okur A; Uyar Göçün P; Karadeniz C
Pediatr Hematol Oncol; 2018 Mar; 35(2):131-144. PubMed ID: 30020823
[TBL] [Abstract][Full Text] [Related]
24. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
25. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
26. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.
Kwong J; Chow LS; Wong AY; Hung WK; Chung GT; To KF; Chan FL; Daigo Y; Nakamura Y; Huang DP; Lo KW
Genes Chromosomes Cancer; 2007 Feb; 46(2):171-80. PubMed ID: 17099870
[TBL] [Abstract][Full Text] [Related]
28. DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma.
Seng TJ; Currey N; Cooper WA; Lee CS; Chan C; Horvath L; Sutherland RL; Kennedy C; McCaughan B; Kohonen-Corish MR
Br J Cancer; 2008 Jul; 99(2):375-82. PubMed ID: 18594535
[TBL] [Abstract][Full Text] [Related]
29. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
30. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
[TBL] [Abstract][Full Text] [Related]
31. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
32. Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma.
Fu L; Gao Z; Zhang X; Tsang YH; Goh HK; Geng H; Shimizu N; Tsuchiyama J; Srivastava G; Tao Q
Int J Cancer; 2009 Apr; 124(7):1572-8. PubMed ID: 19115211
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
34. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
[TBL] [Abstract][Full Text] [Related]
35. Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas.
García MJ; Martínez-Delgado B; Cebrian A; Martínez A; Benítez J; Rivas C
Am J Pathol; 2002 Sep; 161(3):1007-13. PubMed ID: 12213729
[TBL] [Abstract][Full Text] [Related]
36. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
37. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
39. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
[TBL] [Abstract][Full Text] [Related]
40. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
